Ticker HubNasdaq

CV

CapsoVision, Inc. Common Stock

ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS

Latest price

$6.89-1.43%

As of Oct 26, 2026, 4:01 PM EDT · Market data by Massive

Market cap

$371.9M

Volume

104.8K

Previous close

$6.99

Day range

$6.63 – $7.09

Listed

Jul 2, 2025

Coverage

5 articles

Price performance

Recent trading

5 trading days · 15-minute intervals · ET
$7.14$7.03$6.92$6.81$6.70Tue, 10/20Wed, 10/21Thu, 10/22Fri, 10/23Mon, 10/26
Five-day open $6.75Latest interval $6.89

Newsroom

Latest CV coverage

Scholars named for research leadership program to increase diversity in clinical trials
NewsDec 11, 2023

Scholars named for research leadership program to increase diversity in clinical trials

[ad_1] (NewMediaWire) – December 11, 2023 – DALLAS — The American Heart Association — the world’s leading voluntary organization dedicated to a world of longer, healthier lives for all — continues its commitment to address the lack of diversity, equity and inclusion in clinical trials for medical research with the selection of two early-career sc

CILACVCDAFAHA
New USPSTF guidance: Continue to take low-dose aspirin if you have a history of heart attack, AFib, stroke or vascular stenting
NewsApr 26, 2022

New USPSTF guidance: Continue to take low-dose aspirin if you have a history of heart attack, AFib, stroke or vascular stenting

[ad_1] (NewMediaWire) – April 26, 2022 – DALLAS, Tuesday – Earlier today, the U.S. Preventive Services Task Force (USPSTF) released its final recommendations on low-dose aspirin therapy for the primary prevention of cardiovascular disease in adults: people who have a history of heart attack, atrial fibrillation (AFib), stroke or vascular st

FAHACVAHA
SCD
NewsNov 15, 2021

Stem cell therapy for heart failure reduced major CV events and death, not hospitalization

[ad_1] Research Highlights: Adults with chronic, class II or III heart failure with reduced ejection fraction (HFrEF), as defined by the New York Heart Association criteria, who were treated with stem cells experienced a 65% reduction in non-fatal heart attack or stroke events. 
 In NYHA class II heart failure (HF) patients with high levels ...

CVNYHAHF
SCD
NewsNov 14, 2020

New screening questionnaire can identify people at high risk of developing heart disease

[ad_1] Research Highlights: A new study in a Swedish population of middle-aged adults found that four out of 10 people have atherosclerosis, a buildup of fatty deposits that reduce blood flow to the heart. 
 Early detection of coronary artery disease is needed in order to provide preventive treatment and decrease the risk of heart ...

CTCCTALBSCV
Mexico stocks lower at close of trade; S&P/BMV IPC down 0.21% By Investing.com
NewsDec 24, 2018

Mexico stocks lower at close of trade; S&P/BMV IPC down 0.21% By Investing.com

[ad_1] © Reuters. Mexico stocks lower at close of commerce; S&P/BMV IPC down 0.21% Investing.com – Mexico stocks have been lower after the close on Monday, as losses within the , and sectors led shares lower. At the close in Mexico, the declined 0.21%. The greatest performers of the session on the have been El ...

BMVIPCCVMX
Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.